Two documents flank a map of California: one with a marijuana leaf and an X, the other with a checkmark. A scale of justice symbol is shown in the background.

California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look

Rescheduling has reshaped the legal landscape for California Cannabis businesses, but many existing contracts haven't caught up. This post breaks down where supply, licensing, and investment agreements now fall short—covering gaps in DEA registration language, license conversion triggers, and 280E-related representations—and offers a practical framework for reviewing and updating agreements before those gaps become disputes.

u.s. international cannabis marijuana hemp

The Contradictions of Cannabis Law: From the United States to International Treaties

Cannabis law has never been more contradictory. In the U.S., federal and state governments often regulate identical products under completely different legal frameworks. Hemp and marijuana can produce the same intoxicating effects, yet lawmakers treat them as fundamentally different. Medical marijuana now occupies a unique place under federal law while adult use marijuana remains prohibited.

california medical marijuana rescheduling

What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E

Federal rescheduling has finally arrived, but it didn’t magically solve everything for California cannabis businesses. Instead, it created a new set of decisions: whether to pursue DEA registration as a medical operator, how and when to restructure DCC licenses, and what 280E relief actually looks like for mixed medical/adult use companies. This article walks through the concrete steps California operators should take now — including what to do if you missed the initial DEA registration window.

marijuana rescheduling DEA final rule

Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test

While most attention has focused on the recently concluded marijuana rescheduling hearing, an equally significant legal battle has unfolded in the D.C. Circuit over the final rescheduling order ("Final Order").  Petitioners, the Department of Justice, newly intervening parties, and amici participants have exchanged a series of briefs over the past month. Those filings may ultimately

Event banner for “Rescheduling After the Hearing” with four speakers' photos, event details, and information on a live cannabis industry discussion, scheduled for Wednesday, July 22nd, 10-11am PST.

Join Jason Adelstone Tomorrow for The Cannabis Brief LIVE: Cannabis Rescheduling After the Hearing

Tomorrow morning at 10:00 a.m. PT, Harris Sliwoski attorney Jason Adelstone will join fellow cannabis industry professionals for a live webinar, The Cannabis Brief LIVE: Cannabis Rescheduling After the Hearing. The discussion will examine where federal cannabis rescheduling stands following the DEA administrative hearing process, what recent developments mean for the industry, and what cannabis

Webinar banner for "DEA Marijuana Rescheduling Hearings," featuring four speakers, event date July 17, 2026, and a "Live Webinar" label.

Jason Adelstone to Speak on DEA Marijuana Rescheduling Hearing

The DEA's marijuana rescheduling hearing continues to raise important questions for cannabis businesses, investors, and the industry as a whole. If you're trying to keep up with where things stand and what may come next, this upcoming MJBizDaily webinar is worth your time. Harris Sliwoski attorney Jason Adelstone will join a panel of industry professionals

gun control cannabis

Up in Smoke: SCOTUS Torches the Federal Marijuana Gun Ban

Until last week, federal law prohibited marijuana users from owning or possessing firearms, even in states where marijuana is legal. In recent years, we have covered the differing opinions by federal courts challenging this status quo. On June 18, 2026, the Supreme Court held in a 9-0 decision in U.S. v. Hemani that 18 U.S.C.

marijuana rescheduling

Law and Politics: Why Marijuana Rescheduling's One-Sided Hearing Matters

On April 28, 2026, Acting Attorney General Blanche (“AG”) issued a notice of hearing concerning the proposed rule to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). The notice replaced the hearing that began in December 2024 (“2024 Hearing”), which the AG terminated upon issuing the new notice. The

washington lcb cannabis rescheduling

Would Cannabis Rescheduling Help Businesses in Unified Markets? Washington Weighs In

The Washington State Liquor and Cannabis Board (LCB) published an interesting bulletin this Tuesday, June 16th. The bulletin finds that DEA’s final rule on medical marijuana rescheduling “does not appear to apply to Washington’s cannabis licensees, due to the statutory framework predominantly regulating recreational cannabis.” The word “predominantly” is doing a lot of work in

Subscribe To Our Blog

Explore the latest legal news and insight regarding China, cannabis, international law, immigration, dispute resolution and Web3.